Pediatric solid tumors at a glance

Five numbers that define pediatric solid tumors

15–20%

of all childhood cancers are neuroblastoma, Wilms tumor, retinoblastoma, hepatoblastoma, and germ cell tumors combined

NCI PDQ

#1

neuroblastoma is the most common cancer diagnosed in infants and the most common solid tumor outside the brain

NCI PDQ

5cancers

very different embryonal and germ cell cancers, arising from the nervous system, kidney, eye, liver, and reproductive tissue

NCI PDQ

15%

of all childhood cancer deaths are caused by neuroblastoma alone, despite it being only about 8% of cases

Cancers

96%

Wilms tumor 5-year survival for ages 0–14, versus 50–60% for high-risk neuroblastoma

NCI PDQ

Neuroblastoma, Wilms tumor, retinoblastoma, hepatoblastoma, and germ cell tumors together make up roughly 15 to 20% of all childhood cancers.

Source: NCI PDQ · cancer.gov

Neuroblastoma is the most common cancer diagnosed in infants and the most common solid tumor outside the brain in children.

Source: NCI PDQ · cancer.gov

These are not 1 but 5 very different embryonal and germ cell cancers, arising from the nervous system, kidney, eye, liver, and reproductive tissue, each with its own biology and outlook.

Source: NCI PDQ · cancer.gov

Neuroblastoma alone causes about 15% of all childhood cancer deaths despite making up only about 8% of childhood cancer cases, a disproportionately large share of mortality for its size.

Source: Cancers · doi.org

Wilms tumor 5-year survival reaches about 96% for children ages 0 to 14, making it one of the most curable childhood solid tumors, in sharp contrast to high-risk neuroblastoma, where survival is closer to 50 to 60%.

Source: NCI PDQ · cancer.gov

Most common pediatric solid tumors

Neuroblastoma, Wilms tumor, retinoblastoma, hepatoblastoma, and germ cell tumors are the most common solid tumors of childhood outside the brain, bone, and soft tissue. Nearly all occur in infants and very young children, though germ cell tumors also become more common again in adolescence.

Neuroblastoma

Neuroblastoma

The most common cancer that starts outside the brain in young children.

6%

of all childhood cancers in the U.S.

NCI PDQ

81%

overall survival, up from about 72% over the past 15 years

NCI PDQ

50–60%

survival for high-risk disease, versus 95–100% for low-risk disease

NCI PDQ

1 in 5

patients has the MYCN gene change, one of the strongest warning signs in childhood cancer

Cancers

Neuroblastoma is the most common cancer that starts outside the brain in children, making up about 6% of all childhood cancers in the U.S.

Source: NCI PDQ · cancer.gov

Overall survival has risen from about 72% to 81% over the past 15 years.

Source: NCI PDQ · cancer.gov

Survival varies enormously by risk group, from 95 to 100% for low-risk disease down to only 50 to 60% for high-risk disease.

Source: NCI PDQ · cancer.gov

About half of all children diagnosed with neuroblastoma are classified high-risk, usually because they are older than 18 months with cancer that has spread, or have a gene change called MYCN amplification.

Source: NCI PDQ · cancer.gov

About 1 in 5 patients has the MYCN gene change, one of the strongest warning signs in childhood cancer. Survival is only about 50% even with intensive treatment.

Source: Cancers · doi.org

Wilms Tumor

Wilms Tumor

The most common kidney cancer in children, and one of the most curable.

1 in 10,000

children affected, about 5% of all childhood cancers

NCI PDQ

96%

of children ages 0–14 survive at least 5 years

NCI PDQ

<15%

relapse rate with modern treatment, though 30–40% where advanced care is not available

Journal of Surgical Research

94%

of children who survive the first 5 years are still alive 25 years later

Journal of Clinical Oncology

Wilms tumor is the most common kidney cancer in children, affecting about 1 in 10,000 children and making up about 5% of all childhood cancers.

Source: NCI PDQ · cancer.gov

About 96% of children ages 0 to 14 with Wilms tumor survive at least 5 years, one of the most curable childhood solid tumors.

Source: NCI PDQ · cancer.gov

The relapse rate has fallen to under 15% with modern treatment, though it can be much higher, 30 to 40%, where advanced care is not available.

Source: Journal of Surgical Research · doi.org

Once the cancer relapses, survival drops to about 30 to 50%.

Source: Journal of Global Oncology · doi.org

Children who survive the first 5 years do extremely well long-term. About 94% are still alive 25 years later.

Source: Journal of Clinical Oncology · doi.org

Retinoblastoma

Retinoblastoma

The most common eye cancer in children, highly curable when caught early.

300

new U.S. cases each year, and about 9,000 worldwide

Cancer Medicine

4 in 10

cases are inherited, which usually causes tumors in both eyes and at a younger age

Cancer Medicine

97%

U.S. 5-year survival, up from about 92% between 1975 and 2004

Cancer Medicine

<40%

survival in low-income countries, versus over 95% in wealthy countries, mainly due to delayed diagnosis

Asian Pacific Journal of Cancer Prevention

With retinoblastoma, you are fighting for two priceless things at once: your child’s life and your child’s sight. We are incredibly grateful that research has made this cancer highly curable, but as parents, we want more. We want treatments that not only save our children’s lives, but also protect their vision and give them the fullest life possible.
Josie RockMom to retinoblastoma survivor Asher

Retinoblastoma is the most common eye cancer in children, about 300 new U.S. cases and 9,000 cases worldwide each year.

Source: Cancer Medicine · doi.org

It is caused by a change in the RB1 gene. About 4 in 10 cases are inherited, which usually causes tumors in both eyes and at a younger age.

Source: Cancer Medicine · doi.org

In the U.S., 5-year survival rose from about 92% to 97% between 1975 and 2004, and now exceeds 90% in developed countries.

Source: Cancer Medicine · doi.org

This is one of the biggest income-based survival gaps in childhood cancer, over 95% survival in wealthy countries but often under 40% in low-income countries, mainly due to delayed diagnosis.

Source: Asian Pacific Journal of Cancer Prevention · doi.org

Tumor size at diagnosis is the single biggest predictor of survival, bigger than which eye is affected or where a child lives.

Source: The Oncologist · doi.org

Hepatoblastoma

Hepatoblastoma

The most common liver cancer in children.

1–2%

of childhood cancers are liver cancers, and hepatoblastoma is most of that

Cancer Communications

63–82%

overall survival depending on the era studied, reflecting real progress in surgery and chemotherapy

HPB

50–70%

cure rate for advanced-stage disease, much lower than for tumors that can be fully removed by surgery

Cancer Communications

3 in 10

children who reach remission will have their cancer come back

HPB

Liver cancer makes up only about 1 to 2% of childhood cancers, and hepatoblastoma is most of that, about 2.3 cases per million children worldwide.

Source: Cancer Communications · doi.org

Overall survival is about 63 to 82% depending on the era studied, reflecting real progress in surgery and chemotherapy.

Source: HPB · doi.org

Advanced-stage hepatoblastoma is cured 50 to 70% of the time, much lower than for tumors that can be fully removed by surgery.

Source: Cancer Communications · doi.org

About 3 in 10 children who reach remission will have their cancer come back.

Source: HPB · doi.org

Surgery, removing the tumor or, in severe cases, a liver transplant, combined with chemotherapy meaningfully improves survival.

Source: Cancers · doi.org

Germ Cell Tumors

Germ Cell Tumors

A group of tumors arising from the cells that would normally form eggs or sperm, occurring both in and outside the reproductive organs.

3.5%

of childhood cancers

JCO Oncology Practice · NCBI Bookshelf

94%

5-year overall survival for malignant germ cell tumors in a large multicenter cohort

PubMed Central

<50%

long-term survival for choriocarcinoma and mediastinal tumors, the worst-prognosis subtypes

NCBI Bookshelf · PubMed Central

Germ cell tumors are cancers that originate from the cell destined to become either sperm or the egg, and are more commonly known as testicular cancer or ovarian germ cell tumors, although these tumors can arise throughout the body. These tumors are the most common form of cancer in boys/young men and the most common form of ovarian cancer in girls/young women under the age of 30. Although the chemotherapy used since the 1980s results in cure for the majority of patients, it causes many severe long-term side effects. Surviving is not the same as surviving well. Our goal has been to find innovative new therapies that increase chance of cure with fewer long-term side effects.
Lindsay Frazier, MD, ScMInstitute Physician, Dana-Farber Cancer Institute
Professor of Pediatrics, Harvard Medical School
Professor of Epidemiology, Harvard Chan School of Public Health

Pediatric germ cell tumors make up about 3.5% of childhood cancers.

Sources: JCO Oncology Practice · doi.org · NCBI Bookshelf · NBK13572

In a large multicenter cohort, malignant germ cell tumors had a 94% 5-year overall survival.

Source: NCBI PubMed Central · PMC10670163

Yolk sac tumor is the most common malignant subtype, and germinoma is the least aggressive subtype.

Source: NCBI Bookshelf · NBK13572

Choriocarcinoma and mediastinal tumors carry the worst prognosis, with long-term survival below 50%.

Sources: NCBI Bookshelf · NBK13572 · NCBI PubMed Central · PMC10093083

Standard treatment combines complete surgical removal with chemotherapy. Chemotherapy given before surgery is used when a tumor cannot be safely removed right away.

Sources: NCI PDQ (NCBI Bookshelf) · NBK65877 · NCBI PubMed Central · PMC10093083

Life after treatment

After Treatment

Because survival is now high for several of these cancers, the focus has shifted to what treatment leaves behind.

Long-term survivors face an elevated later-life risk of death from treatment effects. Wilms tumor survivors, for example, face nearly 5 times the risk of the general population, mostly from second cancers and heart or lung problems.

Source: Journal of Clinical Oncology · doi.org

Because survival is now so high for several of these cancers, treatment increasingly focuses on preserving organ function and quality of life, such as saving vision in retinoblastoma or a kidney in Wilms tumor, not just survival alone.

Source: Cancer Medicine · doi.org

Chemotherapy can damage the ovaries and reduce the number of remaining eggs, increasing the risk of primary ovarian insufficiency, irregular or absent menstrual periods, early menopause, and reduced fertility. The risk depends on factors including the type and dose of treatment and age at treatment. In general, younger children may have better preservation of ovarian function than adolescents and young adults, although the risk varies substantially by treatment.

Source: Children’s Oncology Group · childrensoncologygroup.org

Traceability

Sources for this page

  • NCI PDQ: Neuroblastoma Treatment · cancer.gov
  • NCI PDQ: Wilms Tumor and Other Childhood Kidney Tumors Treatment · cancer.gov
  • Bartolucci et al., 2022, Cancers: neuroblastoma mortality and MYCN · doi.org
  • Cunningham et al., 2020, Journal of Surgical Research: Wilms tumor relapse · doi.org
  • Njuguna et al., 2017, Journal of Global Oncology: survival after Wilms tumor relapse · doi.org
  • Robison et al., 2009, Journal of Clinical Oncology: long-term survivorship · doi.org
  • Abdelazeem et al., 2022, Cancer Medicine: retinoblastoma incidence and survival · doi.org
  • Handayani et al., 2021, Asian Pacific Journal of Cancer Prevention: global retinoblastoma survival gap · doi.org
  • Guo et al., 2024, The Oncologist: predictors of retinoblastoma survival · doi.org
  • Feng et al., 2019, Cancer Communications: hepatoblastoma incidence and outcomes · doi.org
  • Allan et al., 2013, HPB: hepatoblastoma survival and recurrence · doi.org
  • Yang et al., 2019, Cancers: surgery and transplant in hepatoblastoma · doi.org
  • Frazier et al., 2019, JCO Oncology Practice: pediatric germ cell tumors · doi.org
  • Isaacs, 2013 (NCBI Bookshelf): germ cell tumor subtypes and prognosis · NBK13572
  • Wang et al., 2023 (NCBI PubMed Central): malignant germ cell tumor survival · PMC10670163
  • Li et al., 2023 (NCBI PubMed Central): germ cell tumor treatment and prognosis · PMC10093083
  • NCI PDQ (NCBI Bookshelf): Childhood Extracranial Germ Cell Tumors Treatment · NBK65877
  • Children’s Oncology Group: Ovarian and Reproductive Health after treatment · childrensoncologygroup.org

The National Center for Childhood Cancer is the trusted source for childhood cancer statistics. Designed for journalists and policymakers, every statistic is fully sourced and includes the original source and year of the data to support accurate reporting, informed policy, and better decisions for children with cancer.